Imvexxy (estradiol)

pCPA File Number: 21720
Negotiation Status:
Concluded with an LOI
Indication(s):
Postmenopausal dyspareunia, moderate to severe
Sponsor/Manufacturer:
Knight Therapeutics Inc.
CDA-AMC Project Number:
SR0694-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: